Vect-Horus to Take Part in a Roundtable Discussion at Viva Technology Conference
May 07 2024 - 3:00AM
Marseille, France, May 7th -
Vect-Horus, a privately held biotechnology company that designs and
develops molecular vectors that facilitate the targeted delivery of
therapeutic molecules and imaging agents, today announced its
participation at the Viva Technology conference, taking place in
Paris, France from May 22-25, 2024.
For this event, France’s National Center for
Scientific Research (CNRS) has decided to highlight 10 start-ups
developing disruptive technologies. In the field of Health,
Vect-Horus has been selected to present its VECTrans® technology,
unique in Europe, which represents a breakthrough innovation in
drug targeting to the brain and other pathological tissues (e.g.
cancers).
Vect-Horus Chief Scientific Officer Jean-Manuel
Pean will take part in a roundtable, where he will present an
overview of the Company and its pipeline. He will also highlight
the recent progress made by the Company regarding the optimization
of its VECTrans® technology, the early clinical trial of its
theragnostic agent for glioblastoma and pancreatic cancer, and
update on its different partnerships, including the two recently
concluded licensing agreements with Novo Nordisk and Ionis
Pharmaceuticals.
More details on the definite roundtable program
will be announced closer to the event.
About Vect-Horus
Vect-Horus designs and develops vectors that
facilitate targeting and delivery of therapeutic or imaging agents
to organs, including the brain, and to tumors. Founded in 2005,
Vect-Horus is a spin-off of the Institute for Neurophysiopathology
(INP, UMR7051, CNRS and Aix Marseille University), formerly headed
by Dr Michel Khrestchatisky, co-founder of the company. Vect-Horus
has 38 employees (most in R&D).
To learn more about Vect-Horus,
visit www.vect-horus.com. For more information about this
press release, please contact
Vect-Horus: contact@vect-horus.com.
Contacts
For more information, please contact
Vect-Horus
Emmanuelle Bettendorf, BD & Alliance
Management
Vect-Horus contact@vect-horus.com
Media Relations
Sophie Baumont, Cohesion Bureau -
sophie.baumont@cohesionbureau.com
- 2024-05-07- Vect-Horus_Viva Technology_PR_EN